Cargando…
COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19)
SIMPLE SUMMARY: In two cohorts of vaccinated cancer patients and healthcare workers, 5% had COVID-19 infection after vaccination. These infections occurred more frequently in younger cancer patients with gastrointestinal cancer, gynecological or breast cancer, or a localized cancer and in patients r...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571737/ https://www.ncbi.nlm.nih.gov/pubmed/37835471 http://dx.doi.org/10.3390/cancers15194777 |
_version_ | 1785120071479197696 |
---|---|
author | Seegers, Valérie Rousseau, Guillaume Zhou, Ke Blanc-Lapierre, Audrey Bigot, Frédéric Mahammedi, Hakim Lambert, Aurélien Moreau-Bachelard, Camille Campone, Mario Conroy, Thierry Penault-Llorca, Frédérique Bellanger, Martine M. Raoul, Jean-Luc |
author_facet | Seegers, Valérie Rousseau, Guillaume Zhou, Ke Blanc-Lapierre, Audrey Bigot, Frédéric Mahammedi, Hakim Lambert, Aurélien Moreau-Bachelard, Camille Campone, Mario Conroy, Thierry Penault-Llorca, Frédérique Bellanger, Martine M. Raoul, Jean-Luc |
author_sort | Seegers, Valérie |
collection | PubMed |
description | SIMPLE SUMMARY: In two cohorts of vaccinated cancer patients and healthcare workers, 5% had COVID-19 infection after vaccination. These infections occurred more frequently in younger cancer patients with gastrointestinal cancer, gynecological or breast cancer, or a localized cancer and in patients receiving chemotherapy or targeted therapy when vaccinated. In both cohorts, these breakthrough infections occurred early after initiation of vaccination (Alpha SARS-CoV-2 variant) or several months after the end of vaccination (Omicron SARS-CoV-2 variant). In both cohorts these COVID-19 cases in vaccinated individuals were not severe, with only four cancer patients requiring oxygen therapy. ABSTRACT: In a multicenter prospective cohort of cancer patients (CP; n = 840) and healthcare workers (HCWs; n = 935) vaccinated against COVID-19, we noticed the following: i/after vaccination, 4.4% of HCWs and 5.8% of CP were infected; ii/no characteristic was associated with post-vaccine COVID-19 infections among HCWs; iii/CP who developed infections were younger, more frequently women (NS), more frequently had gastrointestinal, gynecological, or breast cancer and a localized cancer stage; iv/CP vaccinated while receiving chemotherapy or targeted therapy had (NS) more breakthrough infections after vaccination than those vaccinated after these treatments; the opposite was noted with radiotherapy, immunotherapy, or hormonotherapy; v/most COVID-19 infections occurred either during the Alpha wave (11/41 HCW, 20/49 CP), early after the first vaccination campaign started, or during the Omicron wave (21/41 HCW, 20/49 CP), more than 3 months after the second dose; vi/risk of infection was not associated with values of antibody titers; vii/the outcome of these COVID-19 infections after vaccination was not severe in all cases. To conclude, around 5% of our CPs or HCWs developed a COVID-19 infection despite previous vaccination. The outcome of these infections was not severe. |
format | Online Article Text |
id | pubmed-10571737 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105717372023-10-14 COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) Seegers, Valérie Rousseau, Guillaume Zhou, Ke Blanc-Lapierre, Audrey Bigot, Frédéric Mahammedi, Hakim Lambert, Aurélien Moreau-Bachelard, Camille Campone, Mario Conroy, Thierry Penault-Llorca, Frédérique Bellanger, Martine M. Raoul, Jean-Luc Cancers (Basel) Article SIMPLE SUMMARY: In two cohorts of vaccinated cancer patients and healthcare workers, 5% had COVID-19 infection after vaccination. These infections occurred more frequently in younger cancer patients with gastrointestinal cancer, gynecological or breast cancer, or a localized cancer and in patients receiving chemotherapy or targeted therapy when vaccinated. In both cohorts, these breakthrough infections occurred early after initiation of vaccination (Alpha SARS-CoV-2 variant) or several months after the end of vaccination (Omicron SARS-CoV-2 variant). In both cohorts these COVID-19 cases in vaccinated individuals were not severe, with only four cancer patients requiring oxygen therapy. ABSTRACT: In a multicenter prospective cohort of cancer patients (CP; n = 840) and healthcare workers (HCWs; n = 935) vaccinated against COVID-19, we noticed the following: i/after vaccination, 4.4% of HCWs and 5.8% of CP were infected; ii/no characteristic was associated with post-vaccine COVID-19 infections among HCWs; iii/CP who developed infections were younger, more frequently women (NS), more frequently had gastrointestinal, gynecological, or breast cancer and a localized cancer stage; iv/CP vaccinated while receiving chemotherapy or targeted therapy had (NS) more breakthrough infections after vaccination than those vaccinated after these treatments; the opposite was noted with radiotherapy, immunotherapy, or hormonotherapy; v/most COVID-19 infections occurred either during the Alpha wave (11/41 HCW, 20/49 CP), early after the first vaccination campaign started, or during the Omicron wave (21/41 HCW, 20/49 CP), more than 3 months after the second dose; vi/risk of infection was not associated with values of antibody titers; vii/the outcome of these COVID-19 infections after vaccination was not severe in all cases. To conclude, around 5% of our CPs or HCWs developed a COVID-19 infection despite previous vaccination. The outcome of these infections was not severe. MDPI 2023-09-28 /pmc/articles/PMC10571737/ /pubmed/37835471 http://dx.doi.org/10.3390/cancers15194777 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Seegers, Valérie Rousseau, Guillaume Zhou, Ke Blanc-Lapierre, Audrey Bigot, Frédéric Mahammedi, Hakim Lambert, Aurélien Moreau-Bachelard, Camille Campone, Mario Conroy, Thierry Penault-Llorca, Frédérique Bellanger, Martine M. Raoul, Jean-Luc COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) |
title | COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) |
title_full | COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) |
title_fullStr | COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) |
title_full_unstemmed | COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) |
title_short | COVID-19 Infection despite Previous Vaccination in Cancer Patients and Healthcare Workers: Results from a French Prospective Multicenter Cohort (PAPESCO-19) |
title_sort | covid-19 infection despite previous vaccination in cancer patients and healthcare workers: results from a french prospective multicenter cohort (papesco-19) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571737/ https://www.ncbi.nlm.nih.gov/pubmed/37835471 http://dx.doi.org/10.3390/cancers15194777 |
work_keys_str_mv | AT seegersvalerie covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT rousseauguillaume covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT zhouke covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT blanclapierreaudrey covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT bigotfrederic covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT mahammedihakim covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT lambertaurelien covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT moreaubachelardcamille covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT camponemario covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT conroythierry covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT penaultllorcafrederique covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT bellangermartinem covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 AT raouljeanluc covid19infectiondespitepreviousvaccinationincancerpatientsandhealthcareworkersresultsfromafrenchprospectivemulticentercohortpapesco19 |